Quiescent cancer cells with the potential of recurrence form a comfortable environment of fibrillar fibronectin matrix via integrin, ROCK and transforming growth factor β2 (TGF-β2) pathways, whereas an outgrowth would be started by MMP-2-mediated ECM degradation in breast cancer [170]. The gene discussed is MMP2; the disease is cancer.